Psychosocial Factors and Their Association with Clinical Outcomes in Patients with Heart Failure: Why Clinicians Do not Seem to Care

2002 ◽  
Vol 1 (3) ◽  
pp. 183-188 ◽  
Author(s):  
Debra K Moser
Keyword(s):  
Heart Failure ◽  
Clinical Practice ◽  
Psychosocial Factors ◽  
Poor Quality ◽  
Depression And Anxiety ◽  
Increased Risk ◽  
Patients With Heart Failure ◽  
Dissemination Of Research

Poor quality of life, social isolation, depression and anxiety all have been linked to increased risk of rehospitalization and mortality in patients with heart failure. Yet, despite evidence of their importance to outcomes in heart failure patients, psychosocial factors are assessed and treated infrequently in clinical practice. Potential reasons for this include: (1) inadequate dissemination of research about the link between psychosocial factors and outcomes; (2) insufficient training in heart–mind interactions that precludes clinicians from taking advantage of what is known; (3) perceived problems with interventions or with the science of heart–mind interactions that interfere with acceptance of what is known; (4) concerns about how to measure psychosocial factors in clinical practice; and (5) lack of curiosity from clinicians about the role of psychosocial factors in their patients. In this article, each of these possible explanations is explored and recommendations suggested.

Management of Oral Anti-Coagulation in Patients with Heart Failure—Insights from the ThrombEVAL Study

2018 ◽  
Vol 118 (11) ◽  
pp. 1930-1939
Author(s):  
Sebastian Göbel ◽  
Jürgen Prochaska ◽  
Lisa Eggebrecht ◽  
Ronja Schmitz ◽  
Claus Jünger ◽  
...  
Keyword(s):  
Heart Failure ◽  
Adverse Events ◽  
Vitamin K Antagonists ◽  
Plasma Concentrations ◽  
Regular Care ◽  
Increased Risk ◽  
Patients With Heart Failure ◽  
Specialized Care ◽  
The Impact

AbstractPatients with heart failure (HF) are frequently anti-coagulated with vitamin K-antagonists (VKAs). The use of long-acting VKA may be preferable for HF patients due to higher stability of plasma concentrations. However, evidence on phenprocoumon-based oral anti-coagulation (OAC) therapy in HF is scarce. The aim of this study was to assess the impact of the presence of HF on quality of phenprocoumon-based OAC and the subsequent clinical outcome. Quality of OAC therapy and the incidence of adverse events were analysed in a cohort of regular care (n = 2,011) from the multi-centre thrombEVAL study program (NCT01809015) stratified by the presence of HF. To assess the modifiability of outcome, results were compared with data from individuals receiving specialized care for anti-coagulation (n = 760). Overall, the sample comprised of 813 individuals with HF and 1,160 subjects without HF in the regular care cohort. Quality of OAC assessed by time in therapeutic range (TTR) was 66.1% (47.8%/82.8%) for patients with HF and 70.6% (52.1%/85.9%) for those without HF (p = 0.0046). Stratification for New York Heart Classification (NYHA)-class demonstrated a lower TTR with higher NYHA classes: TTRNYHA-I 69.6% (49.4%/85.6%), TTRNYHA-II 66.5% (50.1%/82.9%) and TTRNYHA-≥III 61.8% (43.1%/79.9%). This translated into a worse net clinical benefit outcome for HF (hazard ratio [HR] 1.63 [1.31/2.02]; p < 0.0001) and an increased risk of bleeding (HR 1.40 [1.04/1.89]; p = 0.028). Management in a specialized coagulation service resulted in an improvement of all, TTR (∆+12.5% points), anti-coagulation-specific and non-specific outcome of HF individuals. In conclusion, HF is an independent risk factor for low quality of OAC therapy translating into an increased risk for adverse events, which can be mitigated by specialized care.

scholarly journals The Evolving Role of Catheter Ablation in Patients With Heart Failure and AF

2019 ◽  
Vol 8 (1) ◽  
pp. 47-53
Author(s):  
Sandeep Prabhu ◽  
Wei H Lim ◽  
Richard J Schilling
Keyword(s):  
Heart Failure ◽  
Clinical Practice ◽  
Catheter Ablation ◽  
Patient Group ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Evidence Base ◽  
Patients With Heart Failure ◽  
Recent Developments

AF and heart failure are emerging epidemics worldwide. Several recent trials have provided a growing evidence base for the benefits of catheter ablation in this patient group, which are yet to be universally adopted in clinical practice guidelines. This paper provides a summary of recent developments in this field and provides pragmatic advice to the treating physician regarding the appropriate role of catheter ablation in the overall management of patients with comorbid AF and heart failure.

Mediating Role of Daily Physical Activity on Quality of Life in Patients With Heart Failure

2012 ◽  
Vol 27 (1) ◽  
pp. 16-23 ◽  
Author(s):  
Heng-Hsin Tung ◽  
Ming-Shan Jan ◽  
Chun-Yu Lin ◽  
Shu-Ching Chen ◽  
Hui-Chuan Huang
Keyword(s):  
Quality Of Life ◽  
Physical Activity ◽  
Heart Failure ◽  
Daily Physical Activity ◽  
Mediating Role ◽  
Patients With Heart Failure

The role of physical functioning and depression in quality of life in patients with heart failure

2003 ◽  
Vol 9 (5) ◽  
pp. S5 ◽  
Author(s):  
Teresita Corvera-Tindel ◽  
Lynn V. Doering ◽  
Cleopatra Aquino ◽  
Janice Roper ◽  
Kathleen Dracup
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Physical Functioning ◽  
Patients With Heart Failure

scholarly journals Hubungan Performa Fisik dengan Prognosis Pasien Gagal Jantung

e-CliniC ◽  
2021 ◽  
Vol 9 (1) ◽  
Author(s):  
Nurfadhilah H. Palilati ◽  
Frans E. N. Wantania ◽  
Linda W. A. Rotty
Keyword(s):  
Heart Failure ◽  
Literature Review ◽  
Physical Performance ◽  
Poor Quality ◽  
Google Scholar ◽  
Walking Test ◽  
Patients With Heart Failure ◽  
Failure Prognosis ◽  
The Relationship

Abstract: Heart failure is a serious health problem and a leading cause of death, illness, and poor quality of life. Although the diagnosis and treatment of this disease has significant progress, the prognosis is still poor. The physical performance of patients with heart failure, for example, measured by a 6-minute walking test can be used to assess the functional capacity and assess the prognosis of the patient. This study was aimed to determine the relationship between physical performance and prognosis of patients with heart failure. This was a literature review study using literatures obtained from three databases, namely Pubmed, Science Direct, and Google Scholar. The keywords used in searching the literatures were "physical performance OR 6 minutes walking test AND heart failure prognosis" and their variations and translations. After the selection, 10 literatures were reviewed. The results showed that any decreases in distance of the 6-minute walking test and in walking speed would increase the risk of rehospitalization and mortality as reported in nine literatures. In conclusion, there was a significant relationship between physical performance and prognosis of patients with heart failure.Keywords: physical performance, prognosis of heart failure Abstrak: Gagal jantung merupakan masalah kesehatan yang serius dan penyebab utama kematian, kesakitan, serta kualitas hidup yang buruk. Meskipun diagnosis dan pengobatan penyakit ini telah mengalami banyak kemajuan namun prognosisnya masih buruk. Performa fisik pasien gagal jantung contohnya diukur dengan tes jalan 6 menit dapat digunakan untuk menilai kapasitas fungsional dan menilai prognosis dari pasien. Penelitian ini bertujuan untuk mengetahui hubungan performa fisik dengan prognosis pasien gagal jantung. Jenis penelitian ialah literature review menggunakan  literatur yang diperoleh dari tiga database yaitu Pubmed, Science Direct. dan Google Scholar. Kata kunci yang digunakan dalam pencarian artikel yaitu “physical performance OR 6 minutes walking test AND heart failure prognosis” dan berbagai variasi serta terjemahan. Hasil seleksi, mendapatkan 10 literature yang dikaji. Hasil penelitian mendapatkan bahwa setiap penurunan jarak yang ditempuh dalam uji jalan 6 menit dan penurunan waktu kecepatan berjalan dapat meningkatkan risiko rehospitalisasi dan kematian yang dilaporkan pada 9 literatur. Simpulan penelitian ini ialah terdapat hubungan bermakna antara performa fisik dengan prognosis pada pasien gagal jantung.Kata kunci: performa fisik, prognosis gagal jantung 

Heart Failure

2014 ◽  
pp. 830-842
Author(s):  
Garrick C. Stewart
Keyword(s):  
Heart Failure ◽  
Poor Quality ◽  
Clinical Syndrome ◽  
The Body ◽  
Structural Abnormality ◽  
Cardiac Diseases ◽  
Cardiac Structure ◽  
Patients With Heart Failure ◽  
End Stage

Heart failure is a complex clinical syndrome occurring in patients with an abnormality of cardiac structure or function that impairs the ability of the heart to fill with or eject blood. Patients with heart failure develop a constellation of symptoms (dyspnea and fatigue) and signs (edema and rales) that lead to frequent hospitalizations, poor quality of life, and a shortened life expectancy. Heart failure has also been defined as the failure of the heart to pump enough blood to meet the metabolic demands of the body, or the ability to do so only at elevated filling pressures. Congestive heart failure is the end stage for many cardiac diseases. Cardiomyopathy refers to any condition in which there is a structural abnormality of the myocardium itself.

scholarly journals Integrating palliative care in heart failure: A review article

2018 ◽  
Vol 15 (2) ◽  
pp. 1348
Author(s):  
Gülşah Çamcı ◽  
Sıdıka Oğuz
Keyword(s):  
Quality Of Life ◽  
Heart Failure ◽  
Palliative Care ◽  
Cancer Patients ◽  
Symptom Control ◽  
Poor Quality ◽  
World Health ◽  
Patients With Heart Failure ◽  
Palliative Care Services

Millions of people have heart failure around world. Despite the advances in the care, heart failure has a poor prognosis. Palliative care offers patients a care which achieves symptom control with good quality of life. Palliative care is usually identified with cancer patients but individuals with heart failure also need palliative care. According to the World Health Organization, palliative care is needed mostly by patients with cardiovascular conditions followed by cancer patients. Patients with heart failure suffer from several symptoms, they have poor quality of life and it is difficult to estimate the course of their disease. Patients with heart failure, however, do not receive enough palliative care. Patients with heart failure should have palliative care integrated to their care to ensure that they receive palliative care services. The present study investigated palliative care models offered to patients with heart failures, and examined their outcomes. Several studies have found that heart failure patients who receive palliative care had better symptom management and quality of life and reduced hospitalizations.

Sign in / Sign up

Export Citation Format

Share Document